Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs, Sen. Maggie Hassan (D-N.H.) is accusing the ...

When PBMs refuse to cover the cheaper generic, patients are left on the hook for the full cost. Insurers and employers hire ...

Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can ...

In a letter sent (PDF) to GSK CEO Emma Walmsley, Hassan questioned the company’s recent decision to withdraw its branded Flovent HFA inhaler in favor of an authorized generic from ... costs for its ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

Puff inhalers can be lifesavers for people with asthma and other respiratory diseases, but some types release potent ...

in subjects with asthma compared with healthy control subjects (fig 1 , table 1 ). In contrast, following inhalation of budesonide Cmax and AUC were almost identical in healthy control and asthmatic ...

Aileron Therapeutics has reported positive outcomes from cohort one of the ongoing Phase Ib clinical trial of inhaled LTI-03 in patients with idiopathic ... Trial subjects are randomised into a 3:1 ...